297 related articles for article (PubMed ID: 33728094)
21. Review Devil's tools: SARS-CoV-2 antagonists against innate immunity.
Xu D; Biswal M; Neal A; Hai R
Curr Res Virol Sci; 2021; 2():100013. PubMed ID: 34812428
[TBL] [Abstract][Full Text] [Related]
22. SARS-CoV-2: A Glance at the Innate Immune Response Elicited by Infection and Vaccination.
Manfrini N; Notarbartolo S; Grifantini R; Pesce E
Antibodies (Basel); 2024 Feb; 13(1):. PubMed ID: 38390874
[TBL] [Abstract][Full Text] [Related]
23. Functionality of immune cells in COVID-19 infection: development of cell-based therapeutics.
Sayahinouri M; Mashayekhi Firouz S; Ebrahimi Sadrabadi A; Masoudnia M; Abdolahi M; Jafarzadeh F; Nouripour M; Mirzazadeh S; Zangeneh N; Jalili A; Aghdami N
Bioimpacts; 2023; 13(2):159-179. PubMed ID: 37193075
[No Abstract] [Full Text] [Related]
24. Hold Breath: Autonomic Neural Regulation of Innate Immunity to Defend Against SARS-CoV-2 Infection.
Wang C; Zhao Y; Qiao H; Gao Z; Yang J; Chuai X
Front Microbiol; 2021; 12():819638. PubMed ID: 35310398
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic Targeting of Innate Immune Receptors Against SARS-CoV-2 Infection.
Farooq M; Khan AW; Ahmad B; Kim MS; Choi S
Front Pharmacol; 2022; 13():915565. PubMed ID: 35847031
[TBL] [Abstract][Full Text] [Related]
26. Innate and Adaptive Immunity during SARS-CoV-2 Infection: Biomolecular Cellular Markers and Mechanisms.
Brown B; Ojha V; Fricke I; Al-Sheboul SA; Imarogbe C; Gravier T; Green M; Peterson L; Koutsaroff IP; Demir A; Andrieu J; Leow CY; Leow CH
Vaccines (Basel); 2023 Feb; 11(2):. PubMed ID: 36851285
[TBL] [Abstract][Full Text] [Related]
27. Mucosal Immunity against SARS-CoV-2 in the Respiratory Tract.
Noh HE; Rha MS
Pathogens; 2024 Jan; 13(2):. PubMed ID: 38392851
[TBL] [Abstract][Full Text] [Related]
28. Immune Responses in Patients with COVID-19: An Overview.
Kamat D; Kamat A; Mathur A
Pediatr Ann; 2021 May; 50(5):e222-e226. PubMed ID: 34044706
[TBL] [Abstract][Full Text] [Related]
29. Involvement of Oxidative Stress and the Innate Immune System in SARS-CoV-2 Infection.
Kozlov EM; Ivanova E; Grechko AV; Wu WK; Starodubova AV; Orekhov AN
Diseases; 2021 Feb; 9(1):. PubMed ID: 33668325
[TBL] [Abstract][Full Text] [Related]
30. Combating the challenges of COVID-19 pandemic: Insights into molecular mechanisms, immune responses and therapeutics against SARS-CoV-2.
Negi K; Agarwal M; Pahuja I; Bhardwaj B; Rawat M; Bhaskar A; Dwivedi VP
Oxf Open Immunol; 2023; 4(1):iqad001. PubMed ID: 37051070
[TBL] [Abstract][Full Text] [Related]
31. Experimental Animal Models of Coronavirus Infections: Strengths and Limitations.
Casel MAB; Rollon RG; Choi YK
Immune Netw; 2021 Apr; 21(2):e12. PubMed ID: 33996168
[TBL] [Abstract][Full Text] [Related]
32. Innate immune recognition against SARS-CoV-2.
Yamada T; Takaoka A
Inflamm Regen; 2023 Jan; 43(1):7. PubMed ID: 36703213
[TBL] [Abstract][Full Text] [Related]
33. Immune response to SARS-CoV-2 in children: A review of the current knowledge.
Filippatos F; Tatsi EB; Michos A
Pediatr Investig; 2021 Sep; 5(3):217-228. PubMed ID: 34540321
[TBL] [Abstract][Full Text] [Related]
34. Differences and similarities between innate immune evasion strategies of human coronaviruses.
Hoenigsperger H; Sivarajan R; Sparrer KM
Curr Opin Microbiol; 2024 Jun; 79():102466. PubMed ID: 38555743
[TBL] [Abstract][Full Text] [Related]
35. The Relationship between COVID-19 and Innate Immunity in Children: A Review.
Valentini P; Sodero G; Buonsenso D
Children (Basel); 2021 Mar; 8(4):. PubMed ID: 33808490
[TBL] [Abstract][Full Text] [Related]
36. Suppression and Activation of Intracellular Immune Response in Initial Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Jia L; Chen Z; Zhang Y; Ma L; Wang L; Hu X; Liu H; Chen J; Liu D; Guan W
Front Microbiol; 2021; 12():768740. PubMed ID: 34899651
[TBL] [Abstract][Full Text] [Related]
37. Exploring the Utility of NK Cells in COVID-19.
Deng X; Terunuma H; Nieda M
Biomedicines; 2022 Apr; 10(5):. PubMed ID: 35625739
[TBL] [Abstract][Full Text] [Related]
38. [Role of the immune system in SARS-CoV-2 infection: immunopathology of COVID-19].
Sanz JM; Gómez Lahoz AM; Martín RO
Medicine (Madr); 2021 May; 13(33):1917-1931. PubMed ID: 34075268
[TBL] [Abstract][Full Text] [Related]
39. Innate Immunity Plays a Key Role in Controlling Viral Load in COVID-19: Mechanistic Insights from a Whole-Body Infection Dynamics Model.
Dogra P; Ruiz-Ramírez J; Sinha K; Butner JD; Peláez MJ; Rawat M; Yellepeddi VK; Pasqualini R; Arap W; Sostman HD; Cristini V; Wang Z
ACS Pharmacol Transl Sci; 2021 Feb; 4(1):248-265. PubMed ID: 33615177
[TBL] [Abstract][Full Text] [Related]
40. The Influence of Immune Immaturity on Outcome After Virus Infections.
Shaw ER; Su HC
J Allergy Clin Immunol Pract; 2021 Feb; 9(2):641-650. PubMed ID: 33551039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
